Mixovert Tablet

Mixovert Tabletbelongs to a class of combination therapies designed for vestibular suppression. This ratio is specifically formulated to address vertigo of diverse origins, whether it stems from the inner ear (peripheral) or the brain (central).

Composition and Mechanism: Each tablet contains Cinnarizine and Dimenhydrinate. Cinnarizine works by calming down the balance system in your inner ear, which helps reduce dizziness. Dimenhydrinate helps prevent nausea and vomiting by blocking certain signals in the brain that cause the feeling of motion sickness or spinning. When taken together, these two medicines work better as a team than each one does on its own.

Major Therapeutic Uses: Mixovert Tabletis primarily indicated for the treatment of vertigo of various aetiologies, including peripheral vertigo (like BPPV or Ménière's) and central vertigo (often related to circulatory issues). It is also highly effective for the prevention and treatment of motion sickness (travel sickness) and for the management of associated symptoms such as tinnitus (ringing in the ears) and nystagmus (involuntary eye movements). Because it stabilises the balance system, it is a cornerstone treatment for patients suffering from chronic "dizzy spells" that interfere with walking or standing.

Benefits and Precautions: The primary benefit of Mixovert Tabletis its rapid and comprehensive control over the distressing symptoms of vertigo. It not only stops the room from spinning but also settles the stomach. However, significant precautions are necessary regarding alertness. Both active ingredients can cause significant drowsiness, which other sedatives may intensify. Precautions are also vital for patients with glaucoma or urinary retention, as the antihistamine component can worsen these conditions. It should be used with caution in elderly patients, as it may increase the risk of confusion or dry mouth.

Medical Supervision and Risks: Use of Mixovert Tabletmust be supervised by a healthcare professional. Major risks include extreme sedation and, with long-term use, the potential for "extrapyramidal" symptoms (shaking or stiffness), particularly in older adults. It is contraindicated in patients with severe renal or hepatic impairment and those with angle-closure glaucoma. Patients should be monitored for any signs of allergic reactions or significant mood changes. This medication is generally intended for short-term symptomatic relief; long-term use should be reviewed regularly by a specialist to ensure vestibular compensation is not delayed.

Mixovert Tablet(Cinnarizine 20mg + Dimenhydrinate 40mg) is indicated for:

Vertigo Management

Treating spinning sensations of peripheral or central origin.

Ménière's Disease

Relieving dizziness, nausea, and ear pressure.

Motion Sickness

Preventing vomiting and nausea during travel.

Vestibular Disorders

Stabilising balance after inner ear infections (labyrinthitis).

Tinnitus

Reducing the intensity of ringing in the ears associated with vertigo.

Mixovert Tabletoffers a "dual-anchor" approach to balance health. Its primary medicinal benefit is the simultaneous suppression of the "error signals" sent from the ears to the brain. In many cases of vertigo, the inner ear sends conflicting signals, making the brain think the body is moving when it is not. Cinnarizine acts at the "source" in the ear, while Dimenhydrinate acts at the "receiver" in the brain. This 20mg/40mg dose ensures that the spinning sensation is attacked from both ends of the nervous system, providing faster relief than single-ingredient alternatives.

One of the significant advantages of this combination is its effectiveness against the "vegetative" symptoms of vertigo—namely, nausea and cold sweats. For many patients, the fear of vomiting is as debilitating as the dizziness itself. Dimenhydrinate is exceptionally efficient at blocking the vomiting reflex, allowing the patient to remain calm and hydrated while the vertigo episode passes. This makes the 20mg/40mg dose a reliable "rescue" medication for sudden, severe attacks of dizziness.

Furthermore, Mixovert Tabletis designed to improve the overall quality of life for chronic sufferers. Reducing the frequency and intensity of vertigo spells helps patients overcome the "fear of falling," which often leads to social withdrawal. Because it also improves microcirculation in the inner ear (via Cinnarizine), it can help with long-term stability. For many, this tablet provides the confidence needed to return to a normal routine, ensuring that a balance disorder does not dictate their level of mobility.

Common Side Effects (Generally manageable)

• Drowsiness: Feeling sleepy or tired (very common).

• Dry Mouth: A temporary decrease in saliva production.

• Headache: Mild aching as the body adjusts.

• Stomach Pain: Mild indigestion or discomfort.

• Fatigue: A general feeling of weakness.

Uncommon Side Effects

• Blurred Vision: Difficulty focusing clearly.

• Constipation: Slowed digestive movement.

• Tinnitus: A temporary change in ear ringing.

• Nervousness: Feeling slightly anxious or "jittery."

Serious Side Effects (Requires immediate medical attention)

• Extrapyramidal Symptoms: Trembling, muscle stiffness, or unusual body movements.

• Urinary Retention: Difficulty passing urine (especially in men with prostate issues).

• Skin Reactions: Photosensitivity or a sudden rash.

• Jaundice: Yellowing of the eyes or skin (liver stress).

• Anaphylaxis: Swelling of the face, lips, or throat; difficulty breathing.

• Timing: Usually taken three times daily after meals.
• Method: Swallow the tablet whole with a glass of water. Do not chew.
• With Food: Taking it after a meal reduces the risk of stomach irritation.
• Consistency: For travel sickness, take the dose 30 to 60 minutes before starting the journey.
• Short-Term Use: Use for the duration prescribed; avoid indefinite use without a doctor's review.

This medication works through a "Signal-Suppression" pathway:

1. Labyrinthine Suppression (Cinnarizine): It blocks calcium channels in the inner ear, reducing the "over-firing" of balance nerves.
2. H1-Receptor Blockade (Dimenhydrinate): It blocks histamine in the brain's vomiting centre and vestibular nuclei.
3. Anticholinergic Effect: It reduces the excitability of the vestibular system, making it less sensitive to movement.
4. Coordination Correction: The combination "harmonises" the balance signals, stopping the false sensation of motion.

• The "Stand Up" Rule: To avoid dizziness from a drop in blood pressure, stand up slowly from a sitting or lying position.

• Dry Mouth Relief: Sipping water or using sugar-free gum can help manage the dry mouth caused by the antihistamine.

• Travel Prep: If using for motion sickness, stay hydrated and avoid heavy, greasy meals before your trip.

• Check the Eyes: If you have glaucoma, you must tell your doctor before starting this medicine.

Store Mixovert Tabletat room temperature (below 30°C). Keep the tablets in their original moisture-proof pack. Protect from direct heat, sunlight, and moisture. Keep out of reach of children.

• Alcohol: Significantly worsens the sedative side effects and can lead to loss of balance.
• Grapefruit: No major interaction, but always check with your pharmacist for specific brand instructions.

Drug Name

Severity

Interaction Detail

Sleeping Pills / Sedatives

SEVERE

Combining these can lead to dangerously deep sleep or breathing issues.

Antidepressants (MAOIs)

SEVERE

It can prolong and intensify the medicine's "drying" and sedative effects.

Atropine

MODERATE

Increases the risk of dry mouth, constipation, and blurred vision.

Blood Pressure Meds

CAUTION

May increase the risk of feeling faint when standing up.

• Glaucoma: Can increase internal eye pressure, which is dangerous for those with angle-closure glaucoma.
• Prostate Enlargement: May make it significantly harder to pass urine.
• Parkinson’s Disease: Cinnarizine can rarely worsen tremors or stiffness in these patients.
• Epilepsy: May occasionally lower the seizure threshold; use with caution.

The dosage of Mixovert Tabletis typically based on the severity of the vertigo. For adults, the standard dose is one tablet taken three times daily.

Treatment usually lasts for up to 4 weeks. If the vertigo persists beyond this, your doctor should re-evaluate the cause. For motion sickness, adults should take one tablet 30–60 minutes before travel. Never exceed 3 tablets in 24 hours, as excessive doses can lead to extreme lethargy and confusion. Always follow the specific clinical advice provided by your ENT specialist or GP.

If you miss a dose, take it as soon as you remember with food. However, if it is almost time for your next dose, skip the missed one. Do not take a double dose to catch up, as this will significantly increase the risk of extreme drowsiness and loss of coordination.